Grace Kong is a Nuclear Medicine Physician at the Peter MacCallum Cancer Centre (PMCC) in Melbourne Australia, and a Clinical Senior Lecturer at the University of Melbourne, Sir Peter MacCallum Department of Oncology. She has clinical leadership roles as the Radionuclide Therapy Modality Lead of Cancer Imaging, Chair of the weekly Radionuclide Therapy multidisciplinary meeting (MDM), Molecular imaging lead for Upper Gastrointestinal MDM, and committee of the PMCC ENETS Centre of Excellence. She graduated from Monash University (Australia), completed Physician and Nuclear Medicine training in Melbourne, and a fellowship in PET and radionuclide therapy at the Royal Marsden Hospital and Royal Brompton Hospital in UK. She was the previous Victorian branch chair of the Australian and New Zealand Society of Nuclear Medicine. She has a broad interest in cancer management and has developed a strong experience in using Nuclear Medicine techniques to characterize and to treat malignancies particularly for endocrine and neuroendocrine tumors (NET). She has published many peer-reviewed journals, is the lead author in publications of PRRT outcome data from PMCC and is CPI / PI for several national and international collaborative clinical trials. She participates in research and education as invited speaker at national and international meetings and is a reviewer for several oncology and imaging journals.